Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 24.0B | 24.7B | 23.7B | 25.6B |
| Cost of revenue | 16.8B | 17.9B | 17.1B | 18.7B |
| Gross profit | 7.1B | 6.9B | 6.5B | 6.9B |
| Operating expense | ||||
| Research & development | 849M | 848M | 782M | 870M |
| Selling general and admin | 3.4B | 3.5B | 3.2B | 3.4B |
| Other operating expenses | -46M | 188M | 14M | 100M |
| Operating income | 2.9B | 2.3B | 2.5B | 2.5B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.6B | 2.0B | 2.2B | 2.1B |
| Tax provision | 647M | 423M | 610M | 449M |
| Net income | 1.9B | 1.6B | 1.6B | 1.7B |
| Basic EPS | 4.0 | 3.3 | 3.4 | 3.4 |
| Diluted EPS | 4.0 | 3.3 | 3.4 | 3.4 |
| Basic average shares | 455.4M | 455.4M | 455.4M | 455.4M |
| Diluted average shares | 455.4M | 455.4M | 455.4M | 455.4M |
| EBITDA | 4.1B | 3.4B | 3.6B | 3.7B |
| Net income from continuing op. | 2.9B | 2.3B | 2.5B | 2.5B |
| Minority interests | -152M | -84M | -81M | -134M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |